Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» More Obesity Drugs Seek to Enter Still Struggling Market
More Obesity Drugs Seek to Enter Still Struggling Market
More Obesity Drugs Seek to Enter Still Struggling Market
Submitted by
admin
on September 9, 2014 - 8:08am
Source:
Bloomberg
News Tags:
obesity
Orexigen
Novo Nordisk
NB32
liraglutide
Victoza
Takeda
Headline:
More Obesity Drugs Seek to Enter Still Struggling Market
Do Not Allow Advertisers to Use My Personal information
